NSAIDs with Wellbutrin or Pregabalin: Safety and Precautions
Co-prescribing NSAIDs with Wellbutrin (bupropion) or pregabalin is generally safe with no direct contraindications, but requires monitoring for specific risks: seizure threshold lowering with bupropion, and additive sedation/dizziness with pregabalin.
NSAIDs with Wellbutrin (Bupropion)
Primary Concern: Seizure Risk
The FDA label for Wellbutrin explicitly warns that drugs lowering seizure threshold require "extreme caution" when co-administered 1. While NSAIDs are not specifically listed among high-risk seizure-lowering drugs (unlike antipsychotics, other antidepressants, theophylline, or systemic corticosteroids), the combination warrants attention in patients with additional risk factors.
Key precautions:
- Start with low initial doses of bupropion and titrate gradually when NSAIDs are necessary 1
- Avoid in patients with seizure disorders, eating disorders, or those abruptly discontinuing alcohol/benzodiazepines 1
- Monitor for CNS effects (restlessness, agitation, tremor) as bupropion has dopaminergic activity 1
No Direct Pharmacokinetic Interaction
Bupropion is metabolized via CYP2B6 and inhibits CYP2D6 1. NSAIDs do not significantly interact with these pathways, so no dose adjustments are needed based on metabolism alone.
Cardiovascular Monitoring
Both drug classes require attention to cardiovascular effects:
- NSAIDs can increase blood pressure by ~5 mmHg and worsen heart failure 2, 3
- Bupropion can independently elevate blood pressure 1
- Monitor blood pressure before and during combined therapy, especially in patients with hypertension or cardiovascular disease
NSAIDs with Pregabalin
Primary Concern: Additive CNS Depression
The combination is commonly used and generally well-tolerated, but carries risk of enhanced sedation and dizziness.
Recent evidence supports efficacy:
- A 2019 RCT demonstrated that NSAIDs plus pregabalin significantly reduced sleep disturbances in acute lumbar radicular pain compared to NSAIDs alone 4
- However, adverse events were significantly more frequent with combination therapy 4
- A 2026 thoracotomy study showed pregabalin provided superior opioid-sparing effects compared to naproxen, with slightly higher sedation at 2 hours 5
Key precautions:
- Warn patients about increased dizziness, somnolence, and sedation when combining these medications
- Avoid driving or operating machinery until tolerance is established
- Start pregabalin at lower doses (75-150 mg/day) when combined with NSAIDs
- Monitor elderly patients more closely for falls risk
Renal Considerations
Both drug classes affect renal function:
- NSAIDs impair renal perfusion and cause sodium retention 2, 3
- Pregabalin is renally excreted and requires dose adjustment in renal impairment 6
- Monitor serum creatinine after initiating combination therapy, especially in patients with pre-existing renal disease, heart failure, or those taking ACE inhibitors/ARBs 3
General NSAID Precautions Applicable to Both Combinations
Gastrointestinal Risk
- Use lowest effective dose for shortest duration 2
- Consider PPI co-prescription in patients with history of GI bleeding, age >65, or concurrent anticoagulant use 3
- Risk of serious GI bleeding ranges from 1 in 2,100 (age <45) to 1 in 110 (age >75) per year 3
Cardiovascular Risk
- Avoid COX-2 inhibitors in patients with cardiovascular disease or high cardiovascular risk 2
- All NSAIDs carry cardiovascular risk; use only when no appropriate alternatives exist 2
- Monitor for worsening hypertension, heart failure, or ischemic events 2, 3
Drug-Specific Interactions
If aspirin is used for cardioprotection:
- Take ibuprofen ≥30 minutes after immediate-release aspirin or ≥8 hours before to avoid interference with aspirin's antiplatelet effect 2
- This timing issue does not apply to other NSAIDs like diclofenac 2
Common Pitfalls to Avoid
- Overlooking polypharmacy risks: Recent 2025 data shows NSAID prescriptions average 1.87 drug-drug interactions per prescription 7
- Ignoring renal monitoring: Check creatinine within 1-3 weeks after starting combination therapy in at-risk patients 3
- Underestimating bleeding risk: SSRIs combined with NSAIDs increase bleeding risk; bupropion's mechanism differs but caution remains warranted 8
- Missing substance abuse history: Use pregabalin cautiously in patients with substance abuse history 6
Bottom Line Algorithm
For NSAIDs + Bupropion:
- ✓ Safe to co-prescribe in most patients
- ✓ Monitor blood pressure
- ✓ Use caution if seizure risk factors present
- ✓ Start bupropion low and titrate slowly
For NSAIDs + Pregabalin: